通过移动应用增加帕金森病患者的运动量:试点研究
Jong Hyeon Ahn1, Dongrul Shin2, Dongyeong Lee1
1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea; and Neuroscience Center, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea.
概括
一个新的移动应用程序在两周内显著增加了帕金森病 (PD) 患者的身体活动和改善了他们的生活质量. 这个数字工具显示了增强PD社区的炼坚持和幸福感的前景.
科学领域:
- 神经学 神经学
- 数字健康数字健康
- 运动科学 运动科学
背景情况:
- 运动对于帕金森病 (PD) 管理至关重要.
- 移动应用程序为PD患者所面临的挑战提供了潜在的解决方案.
- 移动炼应用程序对PD患者的影响需要进一步调查.
研究的目的:
- 评估专用移动炼应用程序对帕金森病患者的有效性.
- 评估应用程序对身体活动水平和生活质量的影响.
主要方法:
- 从运动障碍诊所招募了41名PD参与者.
- 参与者在2周内使用了一款专门的家庭炼应用程序.
- 评估身体活动 (IPAQ-SF) 和生活质量 (PDQ-39) 干预前后.
主要成果:
- 平均运动量 (MET-min/week) 从1386.0显著增加到3210.0 (P=0.009).
- 在中等强度的活动和步行方面,有所改善.
- 生活质量得分 (PDQ-39) 显著改善,从17.2升至8.5 (P=0.005).
结论:
- 开发的移动应用程序显示了改善PD患者的运动参与和生活质量的潜力.
- 未来的研究应该涉及电子健康素养,应用程序设计和程序多样性,以获得更好的结果.
- 移动卫生干预可以成为管理帕金森病的宝贵工具.
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541